Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | RORC | P51449 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15610864 | 0.88 | KMT2A (0.54) | KMT2AMEN1MAPTLMNAL3MBTL1 | |
| SCHEMBL15610865 | 0.86 | KMT2A (0.55) | KMT2AMEN1MAPTLMNAL3MBTL1 | |
| SCHEMBL16374998 | 0.82 | SMN1; SMN2 (0.41) | KMT2AMEN1MAPTLMNAL3MBTL1 | |
| SCHEMBL15610829 | 0.78 | KMT2A (0.54) | KMT2AMEN1MAPTLMNAL3MBTL1 | |
| SCHEMBL2494960 | 0.77 | KMT2A (0.59) | KMT2AMEN1MAPTLMNAL3MBTL1 | |
| SCHEMBL2510372 | 0.76 | KMT2A (0.56) | KMT2AMEN1MAPTL3MBTL1ALDH1A1 | |
| SCHEMBL27841972 | 0.76 | SMN1; SMN2 (0.48) | KMT2AMEN1MAPTL3MBTL1ALDH1A1 | |
| SCHEMBL15607950 | 0.75 | KMT2A (0.52) | KMT2AMEN1MAPTLMNAL3MBTL1 | |
| SCHEMBL5603398 | 0.75 | KMT2A (0.60) | KMT2AMEN1MAPTLMNAL3MBTL1 | |
| SCHEMBL6961756 | 0.74 | KMT2A (0.67) | KMT2AMEN1MAPTLMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150010474-A1 | Compounds And Methods For Selective Imaging And/Or Ablation | AUCKLAND UNISERVICES LTD (NL) | 2015-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150010474-A1 | Compounds And Methods For Selective Imaging And/Or Ablation | CBR1, CBR3, BLVRB | KMT2A 2366/4885MEN1 2288/4885MAPT 3982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.